{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:43:19Z","timestamp":1779342199793,"version":"3.51.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1016\/s0889-8588(18)30104-7","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T01:09:05Z","timestamp":1527296945000},"page":"451-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":225,"title":["BCL-2: Prevention of Apoptosis as a Mechanism of Drug Resistance"],"prefix":"10.1016","volume":"9","author":[{"given":"John C.","family":"Reed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0889-8588(18)30104-7_bib1","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1016\/S0021-9258(18)53280-4","article-title":"Apoptosis induced by withdrawal of interleukin-3 [IL-3] from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production","volume":"268","author":"Baffy","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0889-8588(18)30104-7_bib2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","article-title":"Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia","volume":"83","author":"Bedi","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","article-title":"bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death","volume":"74","author":"Boise","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib4","first-page":"786","article-title":"Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor","volume":"8","author":"Bradbury","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/S0889-8588(18)30104-7_bib5","unstructured":"Bronner M, Culin C, Reed JC, Furth EE: Bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol, in press."},{"key":"10.1016\/S0889-8588(18)30104-7_bib6","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood.V81.11.3091.3091","article-title":"High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy","volume":"81","author":"Campos","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood.V84.2.595.595","article-title":"Effects of BCL-2 antisense oligodeoxy- nucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells","volume":"84","author":"Campos","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53- dependent and independent pathways","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0889-8588(18)30104-7_bib9","first-page":"1543","article-title":"Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-mi\/c amplification","volume":"143","author":"Castle","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib10","first-page":"390","article-title":"Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers","volume":"143","author":"Colombel","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.176.4.1043","article-title":"Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents","volume":"176","author":"Collins","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/S0889-8588(18)30104-7_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/j.1460-2075.1993.tb05799.x","article-title":"Programmed cell death by bcl-2- dependent and independent mechanisms in B lymphoma cells","volume":"12","author":"Cuende","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/S0889-8588(18)30104-7_bib13","first-page":"256","article-title":"Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells","volume":"54","author":"de Jong","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib14","first-page":"3253","article-title":"Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma","volume":"54","author":"Dole","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib15","first-page":"1843","article-title":"Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes","volume":"6","author":"Dowd","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib16","first-page":"275","article-title":"Activation of programmed cell death by anticancer agents: cis-platin as a model system","volume":"2","author":"Eastman","year":"1990","journal-title":"Cancer Cells (Cold Spring Harbor)"},{"key":"10.1016\/S0889-8588(18)30104-7_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev.cb.07.110191.003311","article-title":"Mechanisms and functions of cell death","volume":"7","author":"Ellis","year":"1991","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/roi.2970020204","article-title":"Expression of the human Bcl-2 transgene increases the radiation resistance of a hematopoietic progenitor cell line","volume":"2","author":"Epperly","year":"1994","journal-title":"Radiation Oncology Investigations"},{"key":"10.1016\/S0889-8588(18)30104-7_bib19","first-page":"1735","article-title":"Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells","volume":"53","author":"Evans","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib20","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1073\/pnas.88.14.6293","article-title":"p53 in chronic myelogenous leukemia in acute phase","volume":"88","author":"Feinstem","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/366274a0","article-title":"Bcl-2 associates with the ras-related protein R-ras p23","volume":"366","author":"Fernandez-Sarbia","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0889-8588(18)30104-7_bib22","first-page":"3321","article-title":"bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways","volume":"53","author":"Fisher","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib23","first-page":"A630","article-title":"Prognostic relevance of the Bcl-2 translocation in diffuse large cell lymphomas","volume":"7","author":"Gascoyne","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib24","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1073\/pnas.91.15.7350","article-title":"Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2","volume":"91","author":"Gottschalk","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.179.6.1789","article-title":"Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis","volume":"179","author":"Griffiths","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0889-8588(18)30104-7_bib26","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib27","first-page":"4978","article-title":"Production of the p26-Bcl-2 protein in human neuroblastoma cell lines correlates with neuroblastic differentiation and resistance to chemotherapy","volume":"53","author":"Hanada","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(93)80066-N","article-title":"Bcl-2 functions in an antioxidant pathway to prevent apoptosis","volume":"75","author":"Hockenbery","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1097-0142(19930701)72:1<231::AID-CNCR2820720141>3.0.CO;2-5","article-title":"bcl-2 rearrangements in de novo diffuse large cell lymphoma","volume":"72","author":"Jacobson","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0889-8588(18)30104-7_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/361365a0","article-title":"Apoptosis and Bcl-2 protein in cells without mitochondrial DNA","volume":"361","author":"Jacobson","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0889-8588(18)30104-7_bib31","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/j.1460-2075.1994.tb06459.x","article-title":"Programmed cell death and Bcl-2 protection in the absence of a nucleus","volume":"13","author":"Jacobson","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/S0889-8588(18)30104-7_bib32","first-page":"4251","article-title":"bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced F D.N.A. strand breaks and their repair","volume":"53","author":"Kamesaki","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.8235659","article-title":"Bcl-2 inhibition of neural cell death: Decreased generation of reactive oxygen species","volume":"262","author":"Kane","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0889-8588(18)30104-7_bib34","first-page":"5870","article-title":"Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note","volume":"49","author":"Kaufmann","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/ard.1994.4.71","article-title":"Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression","volume":"4","author":"Kitada","year":"1994","journal-title":"Antisense Res Dev"},{"key":"10.1016\/S0889-8588(18)30104-7_bib36","first-page":"2928","article-title":"Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression","volume":"54","author":"Kondo","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib37","unstructured":"Krajewski S, Chatten J, Kanada M, et al: Immunohistochemical analysis of Bcl-2 oncoprotein in human neuroblastoma: Correlations with tumor cell differentiation and N-myc protein. Lab Invest, in press."},{"key":"10.1016\/S0889-8588(18)30104-7_bib38","first-page":"4701","article-title":"Investigations of the subcellular distribution of the BCL-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes","volume":"53","author":"Krajewski","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib39","unstructured":"K\u00fchl J-S, Krajewski S, Dur\u00e1n GE, et al: A spontaneously resistant variant of murine P388 leukemia with broad cross-resistance to cytotoxins and overexpression of the long form of the Bcl-X protein. Submitted."},{"key":"10.1016\/S0889-8588(18)30104-7_bib40","first-page":"686","article-title":"Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells","volume":"7","author":"Lam","year":"1993","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib41","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib42","first-page":"321","article-title":"Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways","volume":"5","author":"Lotem","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/S0889-8588(18)30104-7_bib43","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 is required for radiation-induced apoptosis in mouse thymocytes","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0889-8588(18)30104-7_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.2910530107","article-title":"Bcl-2 proto-oncogene expression in Epstein- Barr-virus associated nasopharyngeal carcinoma","volume":"53","author":"Lu","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/S0889-8588(18)30104-7_bib46","first-page":"455","article-title":"Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT","volume":"6","author":"Makover","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/S0889-8588(18)30104-7_bib47","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1126\/science.8259506","article-title":"How p53 suppresses cell growth","volume":"262","author":"Marx","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0889-8588(18)30104-7_bib48","first-page":"6940","article-title":"Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer","volume":"52","author":"McDonnell","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","article-title":"BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death","volume":"83","author":"McGahon","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib50","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1073\/pnas.91.9.3754","article-title":"Activation of cyclin A-dependent protein kinases during apoptosis","volume":"91","author":"Meikrantz","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib51","first-page":"614","article-title":"The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice","volume":"54","author":"Merritt","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib52","first-page":"5407","article-title":"BCL-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs","volume":"52","author":"Miyashita","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood.V81.1.151.151","article-title":"Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line","volume":"81","author":"Miyashita","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib53a","unstructured":"Miyashita T, Reed JC: Tumor suppressor p 53 is a direct transcriptional activator of BAX gene. Cell, In press."},{"key":"10.1016\/S0889-8588(18)30104-7_bib54","first-page":"3131","article-title":"Identification of a p53-dependent negative response element in the bcl-2 gene","volume":"54","author":"Miyashita","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib55","first-page":"1799","article-title":"Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo","volume":"9","author":"Miyashita","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/S0889-8588(18)30104-7_bib56","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1126\/science.8372353","article-title":"Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice","volume":"261","author":"Nakayama","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0889-8588(18)30104-7_bib57","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.V83.8.2261.2261","article-title":"Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells","volume":"83","author":"Naumovski","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.1989.tb07680.x","article-title":"18q21 rearrangement in diffuse large cell lymphoma: Incidence and clinical significance","volume":"72","author":"Offit","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib59","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood.V77.7.1508.1508","article-title":"Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin\u2019s lymphoma: Clinical correlations","volume":"77","author":"Offit","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib60","first-page":"609","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog","volume":"74","author":"Oltvai","year":"1993","journal-title":"Bax, that accelerates programmed cell death. Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1992.16","article-title":"Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma","volume":"65","author":"Pezzella","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/S0889-8588(18)30104-7_bib62","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM199309023291003","article-title":"bcl-2 protein in non-small-cell lung carcinoma","volume":"329","author":"Pezzella","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0889-8588(18)30104-7_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bjc.1994.61","article-title":"p53 and bcl-2 expression in high- grade B-cell lymphomas: Correlation with survival time","volume":"69","author":"Piris","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/S0889-8588(18)30104-7_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.124.1.1","article-title":"Bcl-2 and the regulation of programmed cell death","volume":"124","author":"Reed","year":"1994","journal-title":"J Cell Biol"},{"issue":"Suppl 1","key":"10.1016\/S0889-8588(18)30104-7_bib65","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/annonc\/5.suppl_1.S61","article-title":"Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin\u2019s lymphoma and lymphocytic leukemia cell lines","volume":"5","author":"Reed","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib66","first-page":"6529","article-title":"Differential expression of the BCL2 proto-oncogene in neuroblastomas and other human neural tumors","volume":"51","author":"Reed","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib67","first-page":"271","article-title":"Regulation of bcl-2 gene expression in lymphoid cell lines containing t(14;18) or normal #18 chromosomes","volume":"4","author":"Reed","year":"1989","journal-title":"Oncogene Research"},{"key":"10.1016\/S0889-8588(18)30104-7_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.annonc.a058361","article-title":"The clinical relevance of t(14;18)\/Bcl-2 rearrangement and Del 6q in diffuse large cell lymphoma and immunoblastic lymphoma","volume":"4","author":"Roumaguera","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib69","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1073\/pnas.91.13.5878","article-title":"c-myc anc bcl-2 modulates p53 function by altering p53 subcellular trafficking during the cell cycle","volume":"91","author":"Ryan","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib70","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib71","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1073\/pnas.91.20.9238","article-title":"Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system","volume":"91","author":"Sato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib72","first-page":"1791","article-title":"Immediate early up-regulation of bax expression by p53 but not TGFbl: A paradigm for distinct apoptotic pathways","volume":"9","author":"Selvakumaran","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/S0889-8588(18)30104-7_bib73","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(91)90361-2","article-title":"bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes","volume":"67","author":"Sentman","year":"1991","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib74","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1073\/pnas.89.15.7003","article-title":"Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice","volume":"89","author":"Siegel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib75","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jnci\/86.7.499","article-title":"The bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients","volume":"86","author":"Silvestrini","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0889-8588(18)30104-7_bib76","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0092-8674(91)90362-3","article-title":"Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship","volume":"67","author":"Strasser","year":"1991","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib76a","unstructured":"Takayama S, Sato T, Krajewski S, et al: Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell, in press."},{"key":"10.1016\/S0889-8588(18)30104-7_bib77","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1073\/pnas.83.14.5214","article-title":"Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma","volume":"83","author":"Tsujimoto","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0889-8588(18)30104-7_bib78","first-page":"347","article-title":"The reciprocal partners of both the t(14;18) and t(11;14) translocations involved in B-cell neoplasms are rearranged by the same mechanism","volume":"2","author":"Tsujimoto","year":"1988","journal-title":"Oncogene"},{"key":"10.1016\/S0889-8588(18)30104-7_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","article-title":"Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair","volume":"75","author":"Veis","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib80","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0092-8674(92)90421-8","article-title":"p53 function and dysfunction","volume":"70","author":"Vogelstein","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0889-8588(18)30104-7_bib81","first-page":"1853","article-title":"Constitutive expression of human Bcl- 2 modulates nitrogen mustard and camptothecin induced apoptosis","volume":"53","author":"Walton","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0889-8588(18)30104-7_bib82","first-page":"2751","article-title":"Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase","volume":"9","author":"Wang","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/S0889-8588(18)30104-7_bib83","first-page":"3427","article-title":"Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line","volume":"8","author":"Wang","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/S0889-8588(18)30104-7_bib84","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas","volume":"317","author":"Weiss","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S0889-8588(18)30104-7_bib85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7696(08)62312-8","article-title":"Cell death, the significance of apoptosis","volume":"68","author":"Wyllie","year":"1980","journal-title":"Int Rev Cytol"},{"key":"10.1016\/S0889-8588(18)30104-7_bib86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/369321a0","article-title":"BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax","volume":"369","author":"Yin","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0889-8588(18)30104-7_bib87","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198904203201605","article-title":"Bcl-2 and other genomic alterations in the prognosis of large-cell lymphomas","volume":"320","author":"Yunis","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S0889-8588(18)30104-7_bib88","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V78.6.1552.1552","article-title":"Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis","volume":"178","author":"Zelenetz","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0889-8588(18)30104-7_bib89","first-page":"4242","article-title":"Induction of cellular p53 activity by DNA-damaging agents and growth arrest","volume":"13","author":"Zhan","year":"1993","journal-title":"Mol Cell Biol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818301047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818301047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:33:06Z","timestamp":1760185986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818301047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["S0889858818301047"],"URL":"https:\/\/doi.org\/10.1016\/s0889-8588(18)30104-7","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[1995,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL-2: Prevention of Apoptosis as a Mechanism of Drug Resistance","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0889-8588(18)30104-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}